ACCURAY WKN: A0MKWM ISIN: US0043971052 Kürzel: XEJ Forum: Aktien Thema: Hauptdiskussion

https://m.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/

Costs Associated with Exit or Disposal Activities, Financial Statements and Exhibits (form 8-K) https://www.marketscreener.com/quote/stock/ACCURAY-INCORPORATED-42550/news/ACCURAY-INC-Costs-Associated-with-Exit-or-Disposal-Activities-Financial-Statements-and-Exhibits--42456755/ ...informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approximately 4.5 percent of its global workforce. The Company expects to substantially complete the cost saving initiative in the second quarter of fiscal 2023. The Company estimates the total cost of this initiative to be approximately $2.0 million, which is expected to be recorded in the second quarter of fiscal 2023.

https://finance.yahoo.com/news/accuray-receives-imv-award-best-131000336.html

https://investors.accuray.com/news-releases/news-release-details/oscar-lambret-center-france-installs-second-accuray-radixactr

https://www.nasdaq.com/articles/accuray-incorporated-q1-loss-increases-misses-estimates Accuray Incorporated Q1 Loss increases, misses estimates

Accuray Reports Fiscal 2023 First Quarter Financial Results https://www.prnewswire.com/news-releases/accuray-reports-fiscal-2023-first-quarter-financial-results-301666588.html Strong customer demand. Navigating FX and Supply Chain Challenges. Company reiterates full year guidance. 

Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration https://www.prnewswire.com/news-releases/accuray-announces-tomo-c-registration-submission-to-chinas-national-medical-products-administration-301664095.html

New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain https://www.prnewswire.com/news-releases/new-reimbursement-approved-by-the-japanese-ministry-of-health-labor-and-welfare-for-the-accuray-cyberknife-system-to-treat-trigeminal-neuralgia-a-condition-often-causing-severe-facial-pain-301659442.html

https://investors.accuray.com/news-releases/news-release-details/ge-healthcare-and-accuray-collaborate-expand-access-advance

Prima

https://www.stockilluminati.com/aray/news.php

Sun Nuclear arbeitet mit Accuray zusammen, um neue Qualitätsmanagementlösungen für das Radixact-System mit Synchrony zu entwickeln

Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting https://www.prnewswire.com/news-releases/accuray-and-c-rad-unveil-automated-breast-cancer-treatment-package-for-the-radixact-system-at-american-society-for-radiation-oncology-astro-annual-meeting-301648231.html ...will showcase an important new option for improving the care of people diagnosed with breast cancer during the 2022 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Antonio, Texas, October 23 – 26, 2022.

https://investors.accuray.com/news-releases/news-release-details/accuray-and-c-rad-unveil-automated-breast-cancer-treatment

In The Lancet Oncology veröffentlichte Daten weisen darauf hin, dass bei Männern mit Prostatakrebs, die mit der Accuray CyberKnife(R)-Plattform behandelt wurden, weniger Blasennebenwirkungen auftraten als bei Männern, die mit herkömmlichen Linearbeschleunigern behandelt wurden https://www.stocktitan.net/news/ARAY/data-published-in-the-lancet-oncology-indicate-men-with-prostate-sab8ayvqf5zx.html

Accuray kündigt erste CyberKnife ® -Systeme in Afrika an, die eine neue Option und Hoffnung auf potenziell lebensrettende Strahlenbehandlungen für mehr Krebspatienten bieten